Immunotherapy, a revolutionary approach in the treatment of cancer and other diseases, has significantly transformed the landscape of modern healthcare. This therapy exploits the body's immune system to fight disease, offering a potent alternative to conventional treatments. This article provides an in-depth understanding of immunotherapy for physicians, facilitating better patient care and treatment outcomes.
Immunotherapy, also known as biotherapy, involves the use of the body's immune system to combat diseases. It can be categorized into two types: active and passive. Active immunotherapy stimulates the immune system to attack disease cells, while passive immunotherapy involves the administration of synthetic immune system proteins.
Immunotherapy has revolutionized cancer treatment by offering alternatives when traditional treatments are ineffective or too aggressive. It can be used alone or in combination with other treatments. Checkpoint inhibitors, CAR-T cell therapy, and therapeutic vaccines are some of the most commonly used types of immunotherapy in oncology.
Recent advancements in immunotherapy include the development of bispecific antibodies, oncolytic virus therapy, and tumor infiltrating lymphocytes (TIL) therapy. These innovations have shown promising results in the treatment of various types of cancer, including melanoma, lung, and breast cancer.
Despite its potential, immunotherapy faces several challenges, including the unpredictability of immune responses and severe side effects. However, ongoing research and technological advancements are expected to address these issues and expand its applicability.
Immunotherapy is a crucial component of modern healthcare, offering hope for better treatment outcomes in various diseases, particularly cancer. As physicians, staying abreast of the latest developments in this field is essential to deliver optimal patient care. Despite the challenges, the future of immunotherapy looks promising with continuous research and innovations.
1.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
2.
Childhood cancer survivors face new health problems later in life, study shows
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Obesity is a major risk factor for cancer
2.
Prevention of Thrombotic Complications in High-Risk Patients
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Hands-on Workshop: Hematology
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation